These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 33299862

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Mitochondrial Pyruvate Carrier 1 as a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer.
    Zou H, Yin Y, Xiong K, Luo X, Sun Z, Mao B, Xie Q, Tan M, Kong R.
    Technol Cancer Res Treat; 2024; 23():15330338241282080. PubMed ID: 39360506
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
    Tian WJ, Liu SS, Li BR.
    Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.
    Zhang MY, Liu XX, Li H, Li R, Liu X, Qu YQ.
    Int J Med Sci; 2018; 15(14):1676-1685. PubMed ID: 30588191
    [Abstract] [Full Text] [Related]

  • 27. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.
    Zhang J, Gu Y, Liu X, Rao X, Huang G, Ouyang Y.
    Biosci Rep; 2020 Jul 31; 40(7):. PubMed ID: 32696952
    [Abstract] [Full Text] [Related]

  • 28. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
    Wei R, Wang Z, Zhang Y, Wang B, Shen N, E L, Li X, Shang L, Shang Y, Yan W, Zhang X, Ma W, Wang C.
    BMC Med Genomics; 2020 Aug 14; 13(1):112. PubMed ID: 32795325
    [Abstract] [Full Text] [Related]

  • 29. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Li Y, Sun N, Lu Z, Sun S, Huang J, Chen Z, He J.
    Cancer Lett; 2017 May 01; 393():40-51. PubMed ID: 28223168
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Long noncoding RNA VPS9D1-AS1 overexpression predicts a poor prognosis in non-small cell lung cancer.
    Tan J, Yang L.
    Biomed Pharmacother; 2018 Oct 01; 106():1600-1606. PubMed ID: 30119235
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer.
    Xiong J, Zhang X, Chen X, Wei Y, Lu DG, Han YW, Xu J, Yu D.
    Oncotarget; 2017 Feb 21; 8(8):13157-13165. PubMed ID: 28061457
    [Abstract] [Full Text] [Related]

  • 36. Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis.
    Qin K, Hou H, Liang Y, Zhang X.
    BMC Cancer; 2020 Apr 16; 20(1):328. PubMed ID: 32299384
    [Abstract] [Full Text] [Related]

  • 37. Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma.
    Kaishang Z, Xue P, Shaozhong Z, Yingying F, Yan Z, Chanjun S, Zhenzhen L, Xiangnan L.
    Life Sci; 2018 Dec 15; 215():159-169. PubMed ID: 30391462
    [Abstract] [Full Text] [Related]

  • 38. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
    Xu XL, Gong Y, Zhao DP.
    Eur Rev Med Pharmacol Sci; 2018 Dec 15; 22(24):8731-8739. PubMed ID: 30575913
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancer.
    Jao K, Tomasini P, Kamel-Reid S, Korpanty GJ, Mascaux C, Sakashita S, Labbé C, Leighl NB, Liu G, Feld R, Bradbury PA, Hwang DM, Pintilie M, Tsao MS, Shepherd FA.
    Lung Cancer; 2018 Sep 15; 123():22-29. PubMed ID: 30089591
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.